Largest pharmaceutical companies in the United States by total assets
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Pfizer leads the 44 pharmaceutical companies in the United States ranked by total assets, at AED 764.6B, ahead of Johnson & Johnson (AED 731.7B) and Merck & Co (AED 502.7B). Figures as of 20 Nov 2026, 06:38 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 44
- First
- PfizerAED 764.6B
- Median
- AED 5.5B
- Combined market value
- AED 13.72T
- Countries
- 1
Market values as of .
United States▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | PfizerPFE · Health Care | AED 764.6B | AED 576.6B | AED 101.15 | 1.85% down | 15% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | AED 731.7B | AED 2.36T | AED 981.21 | 2.04% down | 34% up | ||
| 3 | Merck & CoMRK · Health Care | AED 502.7B | AED 1.2T | AED 487.81 | 3.61% down | 45% up | ||
| 4 | AbbVieABBV · Health Care | AED 492B | AED 1.84T | AED 1,041.44 | 0.86% down | 25% up | ||
| 5 | Eli LillyLLY · Health Care | AED 413.1B | AED 4.42T | AED 4,962.66 | 2.29% down | 33% up | ||
| 6 | Bristol-Myers SquibbBMY · Health Care | AED 330.7B | AED 438B | AED 214.28 | 2.05% down | 30% up | ||
| 7 | Abbott LaboratoriesABT · Health Care | AED 318.5B | AED 660.8B | AED 381.51 | 0.58% down | 16% down | ||
| 8 | Regeneron PharmaceuticalsREGN · Health Care | AED 149B | AED 350.8B | AED 3,391.43 | 2.35% down | 28% up | ||
| 9 | ViatrisVTRS · Health Care | AED 136.6B | AED 83.7B | AED 73.02 | 1.97% down | 99% up | ||
| 10 | Vertex PharmaceuticalsVRTX · Health Care | AED 94.2B | AED 484.9B | AED 1,912.38 | 2.94% down | 27% up | ||
| 11 | Royalty PharmaRPRX · Health Care | AED 72.1B | AED 143B | AED 248.74 | 1.38% down | 79% up | ||
| 12 | ZoetisZTS · Health Care | AED 56.8B | AED 120.6B | AED 296.74 | 5.59% down | 26% down | ||
| 13 | Elanco Animal HealthELAN · Health Care | AED 49.1B | AED 48.3B | AED 96.56 | 1.54% down | 26% up | ||
| 14 | United TherapeuticsUTHR · Health Care | AED 28.9B | AED 87.5B | AED 2,053.57 | 3.16% down | 22% up | ||
| 15 | BioMarin PharmaceuticalBMRN · Health Care | AED 27.9B | AED 43.7B | AED 225.60 | 0.02% down | 17% up | ||
| 16 | Alnylam PharmaceuticalsALNY · Health Care | AED 18.2B | AED 72.7B | AED 542.94 | 1.06% down | 66% down | ||
| 17 | Amneal PharmaceuticalsAMRX · Health Care | AED 13.5B | AED 27.4B | AED 78.57 | 2.24% down | 90% up | ||
| 18 | Ionis PharmaceuticalsIONS · Health Care | AED 12.9B | AED 16.7B | AED 99.98 | 0.62% down | 63% down | ||
| 19 | PTC TherapeuticsPTCT · Health Care | AED 10.6B | AED 17.9B | AED 214.23 | 3.16% down | 21% down | ||
| 20 | InsmedINSM · Health Care | AED 8.3B | AED 116.4B | AED 530.60 | 20.58% up | 40% down | ||
| 21 | Legend BiotechLEGN · Health Care | AED 6.4B | AED 11.5B | AED 59.14 | 0.92% down | 41% down | ||
| 22 | Ligand PharmaceuticalsLGND · Health Care | AED 5.7B | AED 21.1B | AED 1,053.93 | 3.94% down | 50% up | ||
| 23 | CytokineticsCYTK · Health Care | AED 5.2B | AED 26.3B | AED 189.01 | 0.27% up | 19% down | ||
| 24 | Arrowhead PharmaceuticalsARWR · Health Care | AED 5.1B | AED 22.7B | AED 160.33 | 1.25% up | 13% up | ||
| 25 | Madrigal PharmaceuticalsMDGL · Health Care | AED 4.6B | AED 33.9B | AED 1,457.23 | 0.34% down | 27% down | ||
| 26 | TG TherapeuticsTGTX · Health Care | AED 3.9B | AED 36B | AED 238.30 | 1.88% down | 117% up | ||
| 27 | Praxis Precision MedicinesPRAX · Health Care | AED 3.4B | AED 31.9B | AED 1,141.94 | 1.87% up | 86% up | ||
| 28 | Cogent BiosciencesCOGT · Health Care | AED 3.4B | AED 17.7B | AED 101.89 | 0.25% down | 20% down | ||
| 29 | BridgeBio PharmaBBIO · Health Care | AED 3.4B | AED 55.9B | AED 287.16 | 0.22% up | 21% up | ||
| 30 | Mirum PharmaceuticalsMIRM · Health Care | AED 3.1B | AED 22.9B | AED 350.81 | 3.27% up | 34% up | ||
| 31 | Corcept TherapeuticsCORT · Health Care | AED 3.1B | AED 26.1B | AED 238.67 | 4.15% down | 10% down | ||
| 32 | Belite BioBLTE · Health Care | AED 2.9B | AED 22.5B | AED 554.70 | 3.33% down | 43% up | ||
| 33 | Spyre TherapeuticsSYRE · Health Care | AED 2.9B | AED 34.1B | AED 358.59 | 3.77% down | 332% up | ||
| 34 | Summit TherapeuticsSMMT · Health Care | AED 2.8B | AED 31B | AED 38.82 | 0.67% up | 36% down | ||
| 35 | Axsome TherapeuticsAXSM · Health Care | AED 2.5B | AED 26.2B | AED 498.35 | 1.25% up | 6% down | ||
| 36 | Protagonist TherapeuticsPTGX · Health Care | AED 2.5B | AED 29.7B | AED 455.53 | 2.47% down | 51% up | ||
| 37 | Travere TherapeuticsTVTX · Health Care | AED 2.2B | AED 17B | AED 177.41 | 3.86% down | 45% up | ||
| 38 | Edgewise TherapeuticsEWTX · Health Care | AED 2B | AED 16.6B | AED 151.22 | 0.48% down | 86% up | ||
| 39 | Dianthus TherapeuticsDNTH · Health Care | AED 2B | AED 17.5B | AED 311.58 | 1.01% up | 108% up | ||
| 40 | Oruka TherapeuticsORKA · Health Care | AED 1.8B | AED 24.3B | AED 358.37 | 1.91% up | 255% up | ||
| 41 | Rhythm PharmaceuticalsRYTM · Health Care | AED 1.8B | AED 29.7B | AED 429.01 | 1.88% down | 18% up | ||
| 42 | Definium TherapeuticsDFTX · Health Care | AED 1.6B | AED 14.8B | AED 108.28 | 1.24% up | 168% up | ||
| 43 | ErascaERAS · Health Care | AED 1.5B | AED 18.3B | AED 52.23 | 3.34% up | 395% up | ||
| 44 | VeradermicsMANE · Health Care | AED 560.6M | AED 19.3B | AED 456.88 | 0.38% down | 231% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 3.6730 AED).
Questions and answers
Which pharmaceutical companies in the United States rank first by total assets?
Pfizer (AED 764.6B), Johnson & Johnson (AED 731.7B) and Merck & Co (AED 502.7B) are the top three of the 44 pharmaceutical companies in the United States ranked by total assets as of 20 Nov 2026, 06:38 UTC.
How many pharmaceutical companies in the United States are in this ranking?
44 are ranked by total assets.
What are these pharmaceutical companies in the United States worth together?
The 44 pharmaceutical companies in the United States ranked by total assets have a combined market value of AED 13.72T as of 20 Nov 2026, 06:38 UTC.
What does ranking by total assets measure?
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies in the United States by total assets”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=total-assets
Underlying data: Yahoo Finance; SEC EDGAR.